文献速递焦虑、强迫与应激相关障碍

世贸中心救援人员基因表达改变与PTSD症状维度

Altered gene expression and PTSD symptom dimensions in World Trade Center responders.
PubMed 文献 · Mol Psychiatry · 2022-02-17

研究纳入371名世贸中心救援人员,通过全血RNA测序分析基因表达与PTSD症状严重度的关联,并整合现有研究进行meta分析(总N=1016)。发现66个基因与终生最高CAPS总分显著相关,31个与近一月CAPS总分相关,82个与终生焦虑性唤醒症状显著相关;meta分析揭示10个基因达全基因组显著性,均在病例组下调。

要点

  • 终生最高CAPS总分与66个基因显著相关,近一月CAPS总分与31个基因相关。
  • 终生焦虑性唤醒症状维度与82个基因显著相关,多于总分分析所识别基因。
  • Meta分析(总N=1016)发现10个基因达全基因组显著性,病例组均下调。

核心结论

  • PTSD症状维度分析可识别总分分析未达显著性的额外基因,提示PTSD表型异质性存在潜在生物学差异。
  • 未来研究应明确PTSD状态分析方法,基于症状维度的表型可能得出与CAPS总分分析不同的基因集。
  • Meta分析提示的潜在生物标志物可能有助于改善PTSD治疗靶点开发。

研究设计与样本

  • 研究建立371名世贸中心救援人员的良好表型样本,采用分层随机抽样从纵向世贸中心救援人员队列中招募,获取血液、自我报告和临床访谈数据。
  • 使用全血bulk RNA测序,分析基因表达与世贸中心相关PTSD症状严重度的关联,校正性别、年龄、基因型主成分和替代变量。
  • 与现有PTSD研究进行meta分析(总N=1016),以病例/对照状态为预测变量并校正上述变量。

主要发现

  • 66个基因与终生最高CAPS总分显著相关(FDR校正p < 0.05),31个基因与近一月CAPS总分相关。
  • 82个基因与终生焦虑性唤醒症状显著相关。
  • SERPINA1、RPS6KA1和STAT3与多个PTSD症状维度及终生CAPS总分显著相关,既往已报告与PTSD相关。
  • 基因集富集分析识别出代谢、免疫信号、其他精神障碍、神经信号和细胞结构相关通路。
  • Meta分析显示10个基因达全基因组显著性,均在病例组较对照组下调:CIRBP、TMSB10、FCGRT、CLIC1、RPS6KB2、HNRNPUL1、ALDOA、NACA、ZNF429和COPE;细胞去卷积显示PTSD responder较对照富集CD4 T细胞和嗜酸性粒细胞。

局限性

  • 未来研究应明确用于分析PTSD状态的方法,因为基于PTSD症状维度的表型可能得出与联合CAPS评分分析不同的基因集。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Despite experiencing a significant trauma, only a subset of World Trade Center (WTC) rescue and recovery workers developed posttraumatic stress disorder (PTSD). Identification of biomarkers is critical to the development of targeted interventions for treating disaster responders and potentially preventing the development of PTSD in this population. Analysis of gene expression from these individuals can help in identifying biomarkers of PTSD. We established a well-phenotyped sample of 371 WTC responders, recruited from a longitudinal WTC responder cohort using stratified random sampling, by obtaining blood, self-reported and clinical interview data. Using bulk RNA-sequencing from whole blood, we examined the association between gene expression and WTC-related PTSD symptom severity on (i) highest lifetime Clinician-Administered PTSD Scale (CAPS) score, (ii) past-month CAPS score, and (iii) PTSD symptom dimensions using a 5-factor model of re-experiencing, avoidance, emotional numbing, dysphoric arousal and anxious arousal symptoms. We corrected for sex, age, genotype-derived principal components and surrogate variables. Finally, we performed a meta-analysis with existing PTSD studies (total N = 1016), using case/control status as the predictor and correcting for these variables. We identified 66 genes significantly associated with total highest lifetime CAPS score (FDR-corrected p < 0.05), and 31 genes associated with total past-month CAPS score. Our more granular analyses of PTSD symptom dimensions identified additional genes that did not reach statistical significance in our analyses with total CAPS scores. In particular, we identified 82 genes significantly associated with lifetime anxious arousal symptoms. Several genes significantly associated with multiple PTSD symptom dimensions and total lifetime CAPS score (SERPINA1, RPS6KA1, and STAT3) have been previously associated with PTSD. Geneset enrichment of these findings has identified pathways significant in metabolism, immune signaling, other psychiatric disorders, neurological signaling, and cellular structure. Our meta-analysis revealed 10 genes that reached genome-wide significance, all of which were downregulated in cases compared to controls (CIRBP, TMSB10, FCGRT, CLIC1, RPS6KB2, HNRNPUL1, ALDOA, NACA, ZNF429 and COPE). Additionally, cellular deconvolution highlighted an enrichment in CD4 T cells and eosinophils in responders with PTSD compared to controls. The distinction in significant genes between total lifetime CAPS score and the anxious arousal symptom dimension of PTSD highlights a potential biological difference in the mechanism underlying the heterogeneity of the PTSD phenotype. Future studies should be clear about methods used to analyze PTSD status, as phenotypes based on PTSD symptom dimensions may yield different gene sets than combined CAPS score analysis. Potential biomarkers implicated from our meta-analysis may help improve therapeutic target development for PTSD.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Marchese S, Cancelmo L, Diab O, et al. Altered gene expression and PTSD symptom dimensions in World Trade Center responders. Mol Psychiatry. 2022. PMID: 35177824. doi:10.1038/s41380-022-01457-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。